Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis - PubMed (original) (raw)
Clinical Trial
Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis
B L Riggs et al. J Clin Invest. 1972 Jul.
Abstract
In 29 women with postmenopausal osteoporosis, the proportion of total bone surface undergoing resorption or formation was evaluated by microradiography of iliac crest biopsy samples before and after short-term (2(1/2)-4 months) and long-term (26-42 months for estrogen and 9-15 months for anabolic hormone) treatment. After estrogen administration, values for bone-resorbing surfaces decreased, although less prominently after long-term than after short-term therapy. The magnitude of this decrease was positively correlated with the pretreatment value for bone-resorbing surfaces (P < 0.001). When the pretreatment value for bone-resorbing surfaces was used as a covariable, estrogen and anabolic hormone appeared to be equally effective. For bone-forming surfaces, short-term therapy with either hormone had no effect but long-term therapy significantly decreased the values. Serum immunoreactive parathyroid hormone (IPTH) increased significantly after estrogen therapy; the change in IPTH was inversely related to the change in serum calcium (P < 0.001, sign test). We conclude that the primary effect of sex hormones in postmenopausal osteoporosis is to decrease the increased level of bone resorption, perhaps by decreasing the responsiveness of bone to endogenous parathyroid hormone. However, this favorable effect, at least in part, is negated after long-term treatment by a secondary decrease in bone formation. Our data are consistent with the concept that the maximal benefit that can be derived from sex hormone therapy in postmenopausal osteoporosis is arrest or slowing of the progession of bone loss.
Similar articles
- Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
Riggs B, Jowsey J, Kelly PJ, Arnaud CD. Riggs B, et al. Boll Soc Ital Biol Sper. 1973 Jul 30;49(12):732-7. Boll Soc Ital Biol Sper. 1973. PMID: 4364781 No abstract available. - Effect of sex hormones on bone in primary osteoporosis.
Riggs BL, Jowsey J, Kelly PJ, Jones JD, Maher FT. Riggs BL, et al. J Clin Invest. 1969 Jun;48(6):1065-72. doi: 10.1172/JCI106062. J Clin Invest. 1969. PMID: 5771187 Free PMC article. - Effects of oral therapy with calcium and vitamin D in primary osteoporosis.
Riggs BL, Jowsey J, Kelly PJ, Hoffman DL, Arnaud CD. Riggs BL, et al. J Clin Endocrinol Metab. 1976 Jun;42(6):1139-44. doi: 10.1210/jcem-42-6-1139. J Clin Endocrinol Metab. 1976. PMID: 932176 - [Basic principles of hormone replacement therapy in the postmenopause].
Dören M. Dören M. Ther Umsch. 2000 Oct;57(10):628-34. doi: 10.1024/0040-5930.57.10.628. Ther Umsch. 2000. PMID: 11081374 Review. German. - The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR, Bilezikian JP. Rubin MR, et al. Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15. Int J Fertil Womens Med. 2002. PMID: 12081255 Review.
Cited by
- A bioassay for parathyroid hormone and other substances affecting bone metabolism.
McPartlin J, Powell D. McPartlin J, et al. Ir J Med Sci. 1976 Dec;145(1):319. doi: 10.1007/BF02938966. Ir J Med Sci. 1976. PMID: 27517250 - Dietary intake of vitamin K in relation to bone mineral density in Korea adults: The Korea National Health and Nutrition Examination Survey (2010-2011).
Kim MS, Kim ES, Sohn CM. Kim MS, et al. J Clin Biochem Nutr. 2015 Nov;57(3):223-7. doi: 10.3164/jcbn.14-98. Epub 2015 Oct 17. J Clin Biochem Nutr. 2015. PMID: 26566308 Free PMC article. - Diagnosis and management of involutional osteoporosis.
Hodsman PM. Hodsman PM. Can Fam Physician. 1979 Apr;25:467-72. Can Fam Physician. 1979. PMID: 21297728 Free PMC article. - Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.
Ramanadham S, Yarasheski KE, Silva MJ, Wohltmann M, Novack DV, Christiansen B, Tu X, Zhang S, Lei X, Turk J. Ramanadham S, et al. Am J Pathol. 2008 Apr;172(4):868-81. doi: 10.2353/ajpath.2008.070756. Epub 2008 Mar 18. Am J Pathol. 2008. PMID: 18349124 Free PMC article. - ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats.
Do SH, Hwa SY, Jeong WI, Lee JW, Kim HJ, Lee IS, Jeong KS. Do SH, et al. Mol Cell Biochem. 2007 Jan;295(1-2):35-43. doi: 10.1007/s11010-006-9269-5. Epub 2006 Jul 13. Mol Cell Biochem. 2007. PMID: 16838105
References
- Am J Med. 1964 Apr;36:514-28 - PubMed
- J Clin Invest. 1963 Jun;42:885-97 - PubMed
- Clin Chim Acta. 1966 Oct;14(4):563-5 - PubMed
- JAMA. 1966 Apr 18;196(3):219-24 - PubMed
- J Clin Invest. 1969 Jun;48(6):1065-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources